A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

Part of paid clinical trials in San Francisco, California.

Sponsor
Pulmair Medical, Inc.
Study ID
NCT07119229
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Implantable Artificial Bronchus — DEVICE
    The Implantable Artificial Bronchus (IAB) is a tapered, flexible and fenestrated polymer-based airway stent that is implanted bronchoscopically using a proprietary delivery system into diseased lungs of patients with emphysema.

Study Details

A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.

Key Dates

Start date
Mar 25, 2026
Status verified
Jun 2026
Primary completion
Jul 31, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: All subjects will receive study treatment
    All subjects will receive treatment with a maximum of 10 Implantable Artificial Bronchus (IABs) which are polymer based stents that can be permanently placed in any diseased lobe of the lungs.

Primary Outcome Measure

Absolute change in residual volume (RV) [ Time Frame: 90 days after last IAB is implanted ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
Alberto Toledo
[email protected]
415-767-9143
Eric Seeley, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Adriana Martinez
[email protected]
312-926-6680
Momen M Wahidi, MD, MBA (PRINCIPAL_INVESTIGATOR)
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Clinical Researach Coordinator
[email protected]
617-632-8252
Adnan Majid, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By condition
COPD
By specialty
PulmonologyLung disease
By research site
University of California, San Francisco· San Francisco, CANorthwestern University· Chicago, ILBeth Israel Deaconess Medical Center· Boston, MA

Related Studies